Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Yu L, Li L, Medeiros LJ, Young KH.

Blood Rev. 2017 Mar;31(2):77-92. doi: 10.1016/j.blre.2016.10.001. Epub 2016 Oct 13. Review.

PMID:
27773462
2.

Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions.

Baud V, Collares D.

Cells. 2016 May 4;5(2). pii: E22. doi: 10.3390/cells5020022. Review.

3.

API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.

Rosebeck S, Lim MS, Elenitoba-Johnson KS, McAllister-Lucas LM, Lucas PC.

World J Biol Chem. 2016 Feb 26;7(1):128-37. doi: 10.4331/wjbc.v7.i1.128. Review.

4.

The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.

Rosebeck S, Rehman AO, Apel IJ, Kohrt D, Appert A, O'Donnell MA, Ting AT, Du MQ, Baens M, Lucas PC, McAllister-Lucas LM.

Oncogene. 2014 May 8;33(19):2520-30. doi: 10.1038/onc.2013.195. Epub 2013 Jun 17.

5.
6.

Non-canonical NF-κB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2.

Conze DB, Zhao Y, Ashwell JD.

PLoS Biol. 2010 Oct 26;8(10):e1000518. doi: 10.1371/journal.pbio.1000518. Erratum in: PLoS Biol. 2016 Jun;14(6):e1002502.

7.

The IKK complex contributes to the induction of autophagy.

Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, Harper F, Pierron G, Lavandero S, Zitvogel L, Israel A, Baud V, Kroemer G.

EMBO J. 2010 Feb 3;29(3):619-31. doi: 10.1038/emboj.2009.364. Epub 2009 Dec 3.

8.

RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1.

Wang X, Belguise K, O'Neill CF, Sánchez-Morgan N, Romagnoli M, Eddy SF, Mineva ND, Yu Z, Min C, Trinkaus-Randall V, Chalbos D, Sonenshein GE.

Mol Cell Biol. 2009 Jul;29(14):3832-44. doi: 10.1128/MCB.00032-09. Epub 2009 May 11.

9.

Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.

Chin M, Herscovitch M, Zhang N, Waxman DJ, Gilmore TD.

Oncogene. 2009 May 21;28(20):2100-11. doi: 10.1038/onc.2009.74. Epub 2009 Apr 20.

10.

Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.

Noels H, Somers R, Liu H, Ye H, Du MQ, De Wolf-Peeters C, Marynen P, Baens M.

PLoS One. 2009;4(3):e4822. doi: 10.1371/journal.pone.0004822. Epub 2009 Mar 12.

11.

Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.

Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE.

Nat Cell Biol. 2007 Apr;9(4):470-8. Epub 2007 Mar 18.

Supplemental Content

Support Center